Safety and Efficacy of Camrelizumab Combined with Radiotherapy As Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective Single-Arm Phase II Clinical Trial Protocol.

Neoadjuvant chemoradiotherapy followed by esophagectomy is the standard of care for locally advanced esophageal squamous cell carcinoma (ESCC). However, approximately 30 www.clinicaltrials.gov/ , NCT05176002. Registered on 2022/01/04). The posted information will be updated as needed to reflect protocol amendments and study progress.